These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 12833014)
1. Assessment of adapalene gel for the treatment of actinic keratoses and lentigines: a randomized trial. Kang S; Goldfarb MT; Weiss JS; Metz RD; Hamilton TA; Voorhees JJ; Griffiths CE J Am Acad Dermatol; 2003 Jul; 49(1):83-90. PubMed ID: 12833014 [TBL] [Abstract][Full Text] [Related]
2. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Thiboutot DM; Shalita AR; Yamauchi PS; Dawson C; Kerrouche N; Arsonnaud S; Kang S Arch Dermatol; 2006 May; 142(5):597-602. PubMed ID: 16702497 [TBL] [Abstract][Full Text] [Related]
3. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. Capizzi R; Landi F; Milani M; Amerio P Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558 [TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle. Pariser DM; Thiboutot DM; Clark SD; Jones TM; Liu Y; Graeber M; Cutis; 2005 Aug; 76(2):145-51. PubMed ID: 16209161 [TBL] [Abstract][Full Text] [Related]
5. Adapalene gel 0.1% is effective and safe for Japanese patients with acne vulgaris: a randomized, multicenter, investigator-blinded, controlled study. Kawashima M; Harada S; Loesche C; Miyachi Y J Dermatol Sci; 2008 Mar; 49(3):241-8. PubMed ID: 18063345 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris. Thiboutot D; Arsonnaud S; Soto P J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220 [TBL] [Abstract][Full Text] [Related]
8. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris. Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880 [TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy study of adapalene 0.3% gel. Weiss JS; Thiboutot DM; Hwa J; Liu Y; Graeber M J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s24-8. PubMed ID: 18575223 [TBL] [Abstract][Full Text] [Related]
10. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Poulin Y; Sanchez NP; Bucko A; Fowler J; Jarratt M; Kempers S; Kerrouche N; Dhuin JC; Kunynetz R Br J Dermatol; 2011 Jun; 164(6):1376-82. PubMed ID: 21457209 [TBL] [Abstract][Full Text] [Related]
11. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Gollnick HP; Draelos Z; Glenn MJ; Rosoph LA; Kaszuba A; Cornelison R; Gore B; Liu Y; Graeber M; Br J Dermatol; 2009 Nov; 161(5):1180-9. PubMed ID: 19466959 [TBL] [Abstract][Full Text] [Related]
12. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study. Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S; J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423 [TBL] [Abstract][Full Text] [Related]
13. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. Thielitz A; Sidou F; Gollnick H J Eur Acad Dermatol Venereol; 2007 Jul; 21(6):747-53. PubMed ID: 17567301 [TBL] [Abstract][Full Text] [Related]
14. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. Eichenfield LF; Jarratt M; Schlessinger J; Kempers S; Manna V; Hwa J; Liu Y; Graeber M; J Drugs Dermatol; 2010 Jun; 9(6):639-46. PubMed ID: 20645525 [TBL] [Abstract][Full Text] [Related]
15. Is switching retinoids a sound strategy for the treatment of acne vulgaris? Gold LS; Colón LE; Johnson LA; Gottschalk RW J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221 [TBL] [Abstract][Full Text] [Related]
16. The MORE trial: effectiveness of adapalene gel 0.1% in real-world dermatology practices. Gold LS Cutis; 2006 Jul; 78(1 Suppl):12-8. PubMed ID: 16910026 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628 [TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris. Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800 [TBL] [Abstract][Full Text] [Related]
19. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Alirezai M; George SA; Coutts I; Roseeuw DI; Hachem JP; Kerrouche N; Sidou F; Soto P Eur J Dermatol; 2007; 17(1):45-51. PubMed ID: 17324827 [TBL] [Abstract][Full Text] [Related]
20. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]